S1P receptor modulators for treating multiple sclerosis

Details for Australian Patent Application No. 2011201844 (hide)

Owner Novartis AG

Inventors Hiestand, Peter C.; Schnell, Christian

Agent Davies Collison Cave

Pub. Number AU-B-2011201844

Parent 2007264031

Filing date 21 April 2011

Wipo publication date 19 May 2011

Acceptance publication date 25 October 2012

International Classifications

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/397 - having four-membered rings, e.g. azetidine

A61P 37/06 Drugs for immunological or allergic disorders

Event Publications

12 May 2011 Complete Application Filed

19 May 2011 Application Open to Public Inspection

  Published as AU-B-2011201844

25 October 2012 Application Accepted

  Published as AU-B-2011201844

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201845-A cleaning implement

2011201843-Method and apparatus for controlling fluid flow using movable flow diverter assembly